By analyzing the correlation between Trop-2 expression and baseline tumor characteristics, they found that higher Trop-2 expression was associated with apocrine histology, higher androgen receptor (AR) expression, ductal carcinoma in situ (DCIS), lymphovascular invasion (LVI), and lymph node involvement. This evidence concerns the gene TACSTD2 and ductal breast carcinoma in situ.